Hoth Therapeutics, Inc. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD from Q4 2018 to Q1 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary: Hoth Therapeutics, Inc. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and growth rate from Q4 2018 to Q1 2023.
Hoth Therapeutics, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending March 31, 2023 was $11.9M, a 50.5% increase year-over-year.

Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)

Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2023	$11.9M	+$3.98M	+50.5%	Mar 31, 2023	10-Q	2023-05-15
Q1 2022	$7.88M			Mar 31, 2022	10-Q	2023-05-15
Q3 2020	$5.38M	+$1.07M	+24.8%	Sep 30, 2020	10-Q	2020-11-10
Q2 2020	$6.84M	+$2.65M	+63.2%	Jun 30, 2020	10-Q	2020-11-10
Q4 2019	$2.4M	+$2.24M	+1446%	Dec 31, 2019	10-Q	2020-11-10
Q3 2019	$4.31M			Sep 30, 2019	10-Q	2020-11-10
Q2 2019	$4.19M			Jun 30, 2019	10-Q	2020-11-10
Q4 2018	$155K			Dec 31, 2018	10-Q	2020-11-10

* An asterisk sign (*) next to the value indicates that the value is likely invalid.